Literature DB >> 24062416

Evolution of tumefactive lesions in multiple sclerosis: a 12-year study with serial imaging in a single patient.

Vasiliki N Ikonomidou1, Nancy D Richert, Alexander Vortmeyer, Fernanda Tovar-Moll, Bibiana Bielekova, Natalie E Cook, Jeff H Duyn, Francesca Bagnato.   

Abstract

We describe the acute presentation and the long-term evolution of recurrent tumefactive lesions (TLs) in a patient with relapsing-remitting multiple sclerosis. Five TLs occurred on three different occasions over a period of 12 years and these were followed by 73 serial magnetic resonance images (MRI). TL evolution was described by means of magnetization transfer imaging (MTI) and cerebrospinal fluid tissue specific imaging (TSI) over the follow-up period. During the study period, the patient had three clinical relapses with only minimal disability progression. MTI demonstrated that only the peripheral portion of each TL reverted to pre-lesional MT ratios within six months' post-enhancement. Recurring TLs may present a similar pattern of evolution that may be associated with a long-term favourable clinical outcome.

Entities:  

Keywords:  Multiple sclerosis; magnetic resonance imaging; magnetization transfer imaging; recovery; tissue-specific imaging; tumefactive lesion

Mesh:

Substances:

Year:  2013        PMID: 24062416      PMCID: PMC3853337          DOI: 10.1177/1352458513498124

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Authors:  B Bielekova; B Goodwin; N Richert; I Cortese; T Kondo; G Afshar; B Gran; J Eaton; J Antel; J A Frank; H F McFarland; R Martin
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

2.  Optimizing brain tissue contrast with EPI: a simulated annealing approach.

Authors:  Vasiliki N Ikonomidou; Peter van Gelderen; Jacco A de Zwart; Masaki Fukunaga; Jeff H Duyn
Journal:  Magn Reson Med       Date:  2005-08       Impact factor: 4.668

3.  Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.

Authors:  N D Richert; J L Ostuni; C N Bash; T P Leist; H F McFarland; J A Frank
Journal:  Mult Scler       Date:  2001-02       Impact factor: 6.312

4.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

5.  Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space.

Authors:  D L Collins; P Neelin; T M Peters; A C Evans
Journal:  J Comput Assist Tomogr       Date:  1994 Mar-Apr       Impact factor: 1.826

6.  Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.

Authors:  A Altintas; B Petek; N Isik; M Terzi; F Bolukbasi; M Tavsanli; S Saip; C Boz; T Aydin; O Arici-Duz; F Ozer; A Siva
Journal:  Mult Scler       Date:  2012-03-14       Impact factor: 6.312

7.  Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis.

Authors:  Yulin Ge; Robert I Grossman; James S Babb; Marcie L Rabin; Lois J Mannon; Dennis L Kolson
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

8.  Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage.

Authors:  M Riva; V N Ikonomidou; J J Ostuni; P van Gelderen; S Auh; J M Ohayon; F Tovar-Moll; N D Richert; J H Duyn; F Bagnato
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-30       Impact factor: 3.825

9.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.